White crystalline MSM powder in a small glass dish next to a wooden spoon

MSM: A Popular Joint Supplement, Weighed Against the Evidence

Alethia Research Institute · 15 min read · July 2026
TL;DR

MSM, short for methylsulfonylmethane, is a naturally occurring organosulfur compound found in small amounts in various foods and, more relevantly here, sold as a dietary supplement marketed for osteoarthritis pain, joint stiffness, and swelling. Its proposed mechanism centers on sulfur's role in connective tissue formation - sulfur is a necessary building block for the collagen and other structural proteins that make up healthy cartilage, which gives MSM at least a plausible biological rationale even before getting into the clinical trial evidence itself.

What makes MSM worth a careful, separate look is a specific methodological detail buried in how its evidence is often summarized: one of the most frequently cited "MSM doesn't work" verdicts didn't actually evaluate MSM in isolation. Untangling that detail from what the individual, MSM-specific trials actually found turns out to be the most useful thing this article can do.

A researcher's hands sorting through printed study papers, some grouped together and others separate

The Meta-Analysis That Pooled Two Different Compounds

A widely referenced meta-analysis examined both dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) together as related nutritional supplements for knee osteoarthritis, combining data from studies of both compounds into a single overall effect size.

A Combined Analysis, and What Got Blended Together
1.82Combined Effect Size
The overall effect size across the pooled DMSO and MSM studies was 1.82 - neither statistically nor clinically significant, leading the authors to conclude that current evidence suggests neither compound is clinically effective for reducing osteoarthritis pain.
6 StudiesThe Underlying Sample
This conclusion drew on a total of six studies - four examining DMSO (297 patients on active treatment) and two examining MSM specifically (52 patients on active treatment) - meaning MSM's own contribution to this pooled, ultimately negative verdict came from a notably small subset of the overall analysis.
Both PositiveThe MSM-Specific Studies
Notably, both of the individual MSM studies included in this same pooled analysis reported significant improvement in pain outcomes in their treatment groups when considered on their own - a detail that sits somewhat uncomfortably alongside the paper's overall "not clinically effective" conclusion, since it was the pooling with DMSO's more mixed results, and the associated statistical adjustments, that produced the null combined effect.
DMSO and MSM are chemically related (DMSO is actually MSM's precursor compound) but not the same substance, and they're typically used differently - DMSO is frequently applied topically and has a documented garlic-like odor and taste that can compromise study blinding, a real methodological complication distinct from anything relevant to MSM specifically. Combining them into one pooled effect size is a defensible modeling choice in one sense, since they're chemically related, but it also means a reader encountering only the headline "not clinically effective" conclusion may reasonably assume this reflects MSM's own dedicated trial evidence more directly and more negatively than it actually does.
A middle-aged woman gently stretching her knee while seated on a yoga mat at home

What MSM-Specific Trials Have Actually Found

Looking past the combined DMSO-MSM analysis to research examining MSM on its own gives a more encouraging, if still modest, picture.

Significant, Small Trial

2006 Pilot Trial

A randomized, double-blind, placebo-controlled pilot trial gave 50 adults with knee osteoarthritis either MSM (3g twice daily, 6g/day total) or placebo for 12 weeks, measuring outcomes with the WOMAC osteoarthritis index, patient and physician global assessments, and the SF-36 quality of life survey - a genuinely thorough outcome battery for a pilot-sized study.

Significant, Larger Follow-Up

2011 Randomized Controlled Study

A later randomized, double-blind, controlled trial in 49 adults (mean age 68) with confirmed knee osteoarthritis, using MSM at 1.125g three times daily for 12 weeks, found a significant decrease in WOMAC pain and physical function impairment scores (p=0.041 and p=0.045 respectively) compared to placebo.

Inconclusive but Directionally Positive

Earlier Systematic Review (Through 2007)

A systematic review of randomized trials specifically evaluating MSM identified only six qualifying studies published between 1950 and 2007, and reached no definitive conclusion given the limited evidence base - but did note positive trends suggesting MSM may be superior to placebo for mild-to-moderate knee osteoarthritis.

Preclinical, Mechanistically Plausible

Cell and Animal Research

Laboratory studies have found MSM enhances chondrogenic (cartilage-forming) commitment in mesenchymal stem cells and promotes pre-osteoblast formation - genuinely interesting mechanistic support for MSM's proposed role in connective tissue health, though this is cell and animal-level evidence, not a substitute for human trial data.

The Honest, Combined Picture

Taken together, the individual MSM-specific trials point in a genuinely encouraging, if modest, direction - real, statistically significant improvements in validated pain and function measures across at least two separate randomized trials. This sits closer to "promising but still needs a larger, definitive trial" than either "proven effective" or "proven ineffective," which makes the more commonly cited "not clinically effective" headline, drawn from the DMSO-pooled analysis, a meaningfully less complete picture of MSM specifically than the underlying MSM-only research supports.

The Dosing Gap Nobody Has Closed

Beyond the mechanism and efficacy questions, there's a practical gap worth understanding before buying any MSM product: nobody has ever conducted a formal dose-ranging study to establish what the optimal dose actually is.

A Convention, Not a Confirmed Optimum

The commonly suggested oral therapeutic dose for MSM is 4-6g per day, but this figure reflects the doses used across available trials and general practice convention, not a systematically established, dose-ranging-confirmed optimum. Some studies have used doses of up to 20g/day. This is a recurring pattern across several supplements covered on this site - a compound can have genuinely positive individual trial results while still lacking the more basic, foundational research needed to confirm the ideal dose, and MSM fits that pattern clearly.

A Practical Approach

Using MSM Sensibly

If you're considering MSM for mild-to-moderate knee osteoarthritis, the individual trial evidence is genuinely more encouraging than the commonly cited DMSO-pooled meta-analysis suggests - a reasonable, low-risk option to discuss with your physician.
Start within the commonly studied 4-6g/day range, understanding that this reflects trial convention rather than a formally confirmed optimal dose.
Look for USP-verified products, given that MSM, like other dietary supplements, isn't reviewed by the FDA for safety and effectiveness before reaching the market.
Don't take the "not clinically effective" DMSO-MSM meta-analysis conclusion as the definitive word on MSM specifically - the individual MSM-only trials pooled into that same analysis were each independently positive.
Don't expect a dramatic, guaranteed effect - even the more encouraging individual trials describe modest, incremental improvements in pain and function, not a cure.

Dosing

Purpose Typical Studied Dose Notes
Knee osteoarthritis (as studied) 3 - 6g/day, divided doses, minimum 12 weeks Reflects the doses used in the positive individual randomized trials described above; no formal dose-ranging study exists
Safety Notes

MSM appears well tolerated at doses up to 4g/day, with mild gastrointestinal upset, skin rashes, and allergic reactions as the most commonly reported side effects. There are concerns that MSM might interact with anticoagulants (blood thinners), blood pressure medications, and anti-inflammatory drugs - ask a pharmacist to run a drug interaction check before starting, especially if you take any of these. Speak with your physician before starting MSM, purchase from trusted, reliable sources, and keep containers safely out of reach of children and pets.

What It Stacks Well With

🔬

USP-Verified Products

Given the lack of FDA pre-market review for supplements generally, third-party verification is a reasonable, practical safeguard.

🏋️

Appropriate Exercise / Physical Therapy

Movement-based approaches have their own well-established, independent evidence base for osteoarthritis, regardless of supplement choice.

🩺

Standard Osteoarthritis Management

Best positioned as a discussed complement to established medical care, not a replacement for it.

⚠️

Anticoagulant Medication (Caution)

A documented potential interaction - have a pharmacist check before combining.

⚠️

Blood Pressure Medication (Caution)

A documented potential interaction worth flagging with your physician or pharmacist.

⚠️

Anti-Inflammatory Drugs (Caution)

Check for interactions before combining with NSAIDs or other anti-inflammatory medications.

5.5/10
Anti-Aging Factor A supplement whose reputation has been shaped more than it should by a meta-analysis that pooled it with a chemically related but distinct compound, DMSO. Looked at on its own, MSM has small but genuinely positive individual randomized trials behind it for knee osteoarthritis pain and function, alongside plausible cell-level mechanistic support. The score reflects that real, if modest, individual evidence, balanced against the absence of any large, definitive MSM-specific trial and the notable fact that no dose-ranging study has ever established an actual optimal dose.
Glucosamine vs Green-Lipped Mussel
→ The Broader Joint Supplement Comparison

How MSM ranks alongside glucosamine, chondroitin, and green-lipped mussel in a comprehensive 20-supplement review

See our full comparison of joint-health supplements ranked by the same evidence standard.

Sources & Further Reading
  1. Brien, S. et al. Meta-Analysis of the Related Nutritional Supplements Dimethyl Sulfoxide and Methylsulfonylmethane in the Treatment of Osteoarthritis of the Knee. Evidence-Based Complementary and Alternative Medicine.
  2. Kim, L.S. et al. (2006). Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis and Cartilage, 14(3), 286-294.
  3. Debbi, E.M. et al. (2011). Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complementary and Alternative Medicine, 11, 50.
  4. Coppa, C. et al. Methylsulfonylmethane enhances MSC chondrogenic commitment and promotes pre-osteoblasts formation.
  5. ScienceDirect Topics. Methylsulfonylmethane - overview, including systematic review of RCTs 1950-2007.
  6. Poison Control (National Capital Poison Center). Methylsulfonylmethane: a safe treatment for arthritis?

Want the Complete Longevity Stack?

MSM is one piece of the puzzle. Get the full evidence-backed protocol - NMN, D3, Omega-3, dosing, stacking and a 30-day starter plan.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any supplement protocol, especially if you take anticoagulant, blood pressure, or anti-inflammatory medication. Alethia Research Institute is not affiliated with any supplement manufacturer.